1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. SoftOx Solutions AS
  6. Summary
    SOFTX   NO0010811961

SOFTOX SOLUTIONS AS

(SOFTX)
Real-time Oslo Bors  -  10:25 2022-06-28 am EDT
37.20 NOK   +4.94%
06:19aSoftOx Solution Starts Short-term Loan With Almhaug Bolig
MT
06/13SoftOx Solutions AS notes the Norwegian Defence Research Establishment's (FFI) positive data analysis of non-alcohol disinfectants
AQ
05/19SOFTOX SOLUTIONS AS : Announces positive phase 1 results for softox inhalation solution (sis)
AQ
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Real-time Quote. Real-time Oslo Bors
06/22/2022 06/23/2022 06/24/2022 06/27/2022 06/28/2022 Date
35.9(c) 35.8(c) 35.9(c) 35.45(c) 37.2 Last
8 665 8 544 9 642 5 675 18 619 Volume
-2.97% -0.28% +0.28% -1.25% +4.94% Change
More quotes
Estimated financial data (e)
Sales 2020 9,84 M 1,01 M 1,01 M
Net income 2020 -37,4 M -3,83 M -3,83 M
Net cash position 2020 34,8 M 3,56 M 3,56 M
P/E ratio 2020 -15,6x
Yield 2020 -
Sales 2021 7,90 M 0,81 M 0,81 M
Net income 2021 -65,4 M -6,70 M -6,70 M
Net cash position 2021 57,0 M 5,83 M 5,83 M
P/E ratio 2021 -8,86x
Yield 2021 -
Capitalization 367 M 37,5 M 37,5 M
EV / Sales 2020 58,6x
EV / Sales 2021 64,3x
Nbr of Employees 23
Free-Float 56,6%
More Financials
Company
SoftOx Solutions AS is a Norwegian-based medical technology company. The Company has developed a non-toxic and efficient antiseptic technology, which eradicates and prevents biofilm infections. SoftOx Solutions AS is centrally located in Oslo, Norway. 
More about the company
All news about SOFTOX SOLUTIONS AS
06:19aSoftOx Solution Starts Short-term Loan With Almhaug Bolig
MT
06/13SoftOx Solutions AS notes the Norwegian Defence Research Establishment's (FFI) positive..
AQ
05/19SOFTOX SOLUTIONS AS : Announces positive phase 1 results for softox inhalation solution (s..
AQ
05/18SoftOx Solutions AS Announces Positive Phase 1 Results for SoftOx Inhalation Solution
CI
05/18SOFTOX SOLUTIONS AS : to attend and host an educational symposium at the European Wound Ma..
AQ
05/12SOFTOX SOLUTIONS AS : Annual general meeting held
AQ
05/11SOFTOX SOLUTIONS AS : The SBE-01 phase 1 clinical study enters the final phase 1b
AQ
05/10SoftOx Solutions AS Announces the Last Patient Completes the Last Single-Dose Cohort of..
CI
05/05SOFTOX SOLUTIONS AS : Notice of Annual General Meeting
AQ
05/04SOFTOX SOLUTIONS AS : Annual Report 2021
AQ
05/04SOFTOX : Guidelines for remuneration 2022_SoftOx Solutions AS
PU
05/04SOFTOX : Articles of association 2022_SoftOx Solutions AS
PU
05/04SOFTOX : 561276_Notice of Annual General Meeting 2022_SoftOx Solutions AS
PU
05/04SOFTOX : Nomination committee recommentations 2022_SoftOx Solutions AS
PU
04/28SOFTOX SOLUTIONS AS : Announces advancement into next phase (1b) in the SBE project
AQ
More news
News in other languages on SOFTOX SOLUTIONS AS
05/18SoftOx Solutions AS annonce des résultats positifs de la phase 1 pour la solution d'inh..
05/10SoftOx Solutions AS annonce que le dernier patient termine la dernière cohorte à dose u..
04/28Softox Solutions AS annonce l'avancement de la phase suivante (1B) du projet SBE
04/28SoftOx Solutions AS annonce ses résultats pour le premier trimestre clos le 31 mars 202..
01/24SoftOx Solutions AS annonce des changements concernant la demande d'approbation nationa..
More news
Chart SOFTOX SOLUTIONS AS
Duration : Period :
SoftOx Solutions AS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOFTOX SOLUTIONS AS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Geir Hermod Almňs Chief Executive Officer
Kristine Mundal R°d Chief Financial Officer
Melvin Teigen Chairman
Glenn Gundersen Medical Director
Magnus Mustafa Fazli Head-Science & Research
Sector and Competitors
1st jan.Capi. (M$)
SOFTOX SOLUTIONS AS-35.89%38
GILEAD SCIENCES, INC.-13.12%79 122
VERTEX PHARMACEUTICALS33.22%74 821
REGENERON PHARMACEUTICALS, INC.-3.01%65 993
WUXI APPTEC CO., LTD.-12.75%44 742
BIONTECH SE-48.01%32 574